139 related articles for article (PubMed ID: 35308759)
1. Evaluation of Safety for Scanning Carbon-Ion Radiotherapy in Hemodialysis Patients With Prostate Cancer.
Takakusagi Y; Suga M; Kusano Y; Kano K; Shima S; Tsuchida K; Mizoguchi N; Serizawa I; Yoshida D; Kamada T; Minohara S; Katoh H
Cureus; 2022 Feb; 14(2):e22214. PubMed ID: 35308759
[TBL] [Abstract][Full Text] [Related]
2. Five-year clinical outcomes of scanning carbon-ion radiotherapy for prostate cancer.
Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
PLoS One; 2024; 19(3):e0290617. PubMed ID: 38457424
[TBL] [Abstract][Full Text] [Related]
3. Interfractional robustness of scanning carbon ion radiotherapy for prostate cancer: An analysis based on dose distribution from daily in-room CT images.
Tsuchida K; Minohara S; Kusano Y; Kano K; Anno W; Takakusagi Y; Mizoguchi N; Serizawa I; Yoshida D; Imura K; Takayama Y; Kamada T; Katoh H; Ohno T
J Appl Clin Med Phys; 2021 Jun; 22(6):130-138. PubMed ID: 34046997
[TBL] [Abstract][Full Text] [Related]
4. Safety of Carbon-ion Radiotherapy for Prostate Cancer After Rectal Cancer Surgery.
Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
Anticancer Res; 2023 Jun; 43(6):2691-2695. PubMed ID: 37247892
[TBL] [Abstract][Full Text] [Related]
5. Carbon-Ion Radiotherapy Using Metal Artifact Reduction Computed Tomography in a Patient with Prostate Cancer with Bilateral Hip Prostheses: A Case Report.
Takakusagi Y; Takayama Y; Kusano Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Miyakawa S; Imura K; Katoh H
Case Rep Oncol; 2022; 15(3):894-901. PubMed ID: 36825095
[TBL] [Abstract][Full Text] [Related]
6. Clinical Efficacy and Safety of Proton and Carbon Ion Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis.
Li M; Li X; Yao L; Han X; Yan W; Liu Y; Fu Y; Wang Y; Huang M; Zhang Q; Wang X; Yang K
Front Oncol; 2021; 11():709530. PubMed ID: 34712607
[TBL] [Abstract][Full Text] [Related]
7. Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study.
Li P; Hong Z; Li Y; Fu S; Zhang Q
Front Oncol; 2021; 11():808216. PubMed ID: 35223457
[TBL] [Abstract][Full Text] [Related]
8. Carbon ion radiotherapy for prostate cancer with bladder invasion.
Miyasaka Y; Kawamura H; Sato H; Kubo N; Mizukami T; Matsui H; Miyazawa Y; Ito K; Nakano T; Suzuki K; Ohno T
BMC Urol; 2021 Aug; 21(1):106. PubMed ID: 34362355
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
11. Salvage Carbon Ion Radiation Therapy for Locally Recurrent or Radiation-Induced Second Primary Sarcoma of the Head and Neck.
Yang J; Gao J; Wu X; Hu J; Hu W; Kong L; Lu JJ
J Cancer; 2018; 9(12):2215-2223. PubMed ID: 29937942
[No Abstract] [Full Text] [Related]
12. Preliminary exploration of clinical factors affecting acute toxicity and quality of life after carbon ion therapy for prostate cancer.
Zhang Y; Li P; Yu Q; Wu S; Chen X; Zhang Q; Fu S
Radiat Oncol; 2019 Jun; 14(1):94. PubMed ID: 31164172
[TBL] [Abstract][Full Text] [Related]
13. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
Bridges D; Kawamura H; Kanai T
PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
[TBL] [Abstract][Full Text] [Related]
14. Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety.
Akbaba S; Lang K; Held T; Bulut OC; Mattke M; Uhl M; Jensen A; Plinkert P; Rieken S; Herfarth K; Debus J; Adeberg S
Cancers (Basel); 2018 Oct; 10(10):. PubMed ID: 30340397
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric Comparison Between Carbon-ion Radiotherapy and Photon Radiotherapy for Stage I Esophageal Cancer.
Takakusagi Y; Yoshida D; Kusano Y; Kano K; Anno W; Tsuchida K; Mizoguchi N; Serizawa I; Katoh H; Imura K; Takayama Y; Minohara S; Kamada T
In Vivo; 2021; 35(1):447-452. PubMed ID: 33402495
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks.
Nomiya T; Tsuji H; Maruyama K; Toyama S; Suzuki H; Akakura K; Shimazaki J; Nemoto K; Kamada T; Tsujii H;
Br J Cancer; 2014 May; 110(10):2389-95. PubMed ID: 24722181
[TBL] [Abstract][Full Text] [Related]
17. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
18. Landscape of Carbon Ion Radiotherapy in Prostate Cancer: Clinical Application and Translational Research.
Chen X; Yu Q; Li P; Fu S
Front Oncol; 2021; 11():760752. PubMed ID: 34804961
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Dose Distribution Between VMAT-SBRT and Scanning Carbon-ion Radiotherapy for Early-stage NSCLC.
Yoshida D; Kusunoki T; Takayama Y; Kusano Y; Minohara S; Kano K; Anno W; Tsuchida K; Takakusagi Y; Mizoguchi N; Serizawa I; Ebara T; Katoh H
Anticancer Res; 2021 Sep; 41(9):4571-4575. PubMed ID: 34475085
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
